Alkhouri N, Herring R, Kabler H et al (2022) Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial
Clinical research indicates that topical hyaluronic acid poses minimal risk during pregnancy
EweysAZhaoYZhangJXiaoXBaiJDarweshOet al
Pearce SHS, Cheetham TD, Wood CL, Gan EH, Perros P
TD oestrogen does not increase the risk of venous thromboembolism (VTE) and is therefore recommended for all women with an increased background risk of VTE, including a BMI 30 kg/m 2
Several medications have entered phase 2 or 3 of clinical trials for PWS patients ( and this therapeutic approach of appetite modulation via the hypothalamus could provide promising results not only in PWS patients, but also for patients with other types of hypothalamic obesity